Image of copper and zinc pieces.
Source: Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Surefire Resources NL (ASX:SNL) has discovered a large zone of copper and zinc mineralisation east of its Yidby Gold Project in Western Australia, through soil sampling work which showed anomalous assays across a 5 by 2 kilometre zone.

The soil samples have now been assessed in a laboratory, and show grades of up to 1000 parts per million (ppm) nickel, 310 ppm copper, 100 ppm zinc, 100 ppm cobalt, and 452 ppm sulphur.

Excitingly, many of the assays revealed grades of more than 200 ppm copper.

Exploration picked up some other key finds, including a rock sample – taken from a gossan – which was enriched with grades of 270 ppm nickel, 460 ppm copper, 200 ppm zinc and 100 ppm cobalt.

Finally, gold and sulphides were also identified in Banded Iron Formation during the exploration work, with this being adjacent to the soil sampling area.

What Surefire has found here is enhanced by the knowledge that only 30 kilometres to the northwest is 29Metals’ Golden Grove deposit – identified as a Volcanogenic Hosted Massive Sulphide (VHMS) system which holds a similar geological setting to the one found here.

Previous exploration samples from this zone near Yidby have yielded assays of up to 101 ppm gold.

Surefire shares are trading higher on the news. At 12:56 AEST, they were trading at 0.7 cents – a rise of 16.67% since the market opened.

SRN by the numbers
More From The Market Online
Nuclear explosion mushroom cloud concept

Week 47 Wrap: HotCopper users’ most watched; Brent lifts on Putin’s scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching…
Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse

The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in th…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…